On September 5, 2025, BioSig Technologies, Inc. held a special meeting where stockholders approved several proposals, including increasing the shares under the 2023 Long-Term Incentive Plan by 10,359,211, raising authorized common stock from 200 million to 500 million, and approving issuances related to convertible debentures and equity agreements.